Objective intake data for your study
DoryGo records each compartment opening — passively, at dose level and for the full regimen. Your analysis works with measured intake instead of diaries, pill counts or refill records.

Not running a study?
Same product, different entry point.
01 — The problem
Adherence is measured with the methods least able to capture it
Adherence is a variable in almost every study involving oral medication. In most protocols it is still assessed through diaries, returned-pill counts or refill records — methods that show whether medication was available, not whether and when it was taken.
Diaries and pill counts are indirect
Both depend on what participants record or bring back. Neither shows when a dose was taken.
Single-container monitors stop at one drug
Electronic caps record openings of one container. With several medications, each needs its own device, or some go unmeasured.
Intake and effect are confounded
Without measured intake, a weak treatment effect cannot be told apart from a treatment that was not taken as specified.
of plasma samples contained the study drug, while self-report and returned pill counts indicated 86–90% adherence (HIV prevention trial, women in South Africa, Uganda and Zimbabwe).
Source: Marrazzo et al., New England Journal of Medicine, 2015 (VOICE trial)
02 — For your study
Intake as a measured variable, not an assumption
Each compartment opening is recorded as a timestamped event.
One blister holds all oral medication of a participant, so one device covers the regimen.
No diary, no app confirmation. Participants open the compartment as usual; the box records it.
Measured intake changes what a study can say. It separates the effect of a treatment from the extent to which it was taken, supports per-protocol analyses on recorded rather than assumed intake, and allows timing — not only the number of doses — to enter the analysis.
We provide the measurement and its documentation; the analysis stays with your team. The measurement principle and its limitations are described so that they can be stated in a methods section.
DoryGo records the opening of each blister compartment. As with all electronic monitoring, an opening is a proxy for intake: it shows reliably when a dose was not accessed, but not that it was swallowed.
03 — The product
Three parts, one continuous record
Pre-sorted multi-dose blister
A pharmacy sorts the full regimen into dated, time-labelled compartments, so the patient never assembles a dose themselves.
- —One compartment per intake time, printed with date and patient name
- —Regimen changes handled at the pharmacy, not by the patient
- —Removes the manual weekly re-sorting step entirely

Sensor pill box
A new blister is inserted each day. The box registers each compartment opening passively — no app step, no confirmation, nothing else for the patient to remember.
- —Timestamped event per opening, at compartment level
- —Built-in eSIM; if there is no connection, events are stored on the box and sent on reconnect
- —Works for patients who do not use a smartphone

Patient app and dashboard
Patients see their own schedule and history. Your team sees recorded intake across all participating patients, sorted by missed and late doses.
- —Overview of all participating patients, sorted by missed and late doses
- —Intake history per patient
- —Role-based access; export via FHIR or CSV

04 — Workflow
From the pharmacy bench to your team, in five steps
05 — How step 1 is set up
Blistering runs through a licensed pharmacy partner in your market
The pre-sorting is carried out by a local, licensed pharmacy partner, which we identify and set up together with your organisation. Dispensing stays where it is already regulated and already trusted. We equip that pharmacy with the sealing machine, the blisters and the foils, and we supply the box, the app, the dashboard and the integration.
National rules for dispensing, repackaging and medical-device classification differ, and they determine what is possible in your market. We clarify this per country before a pilot is scoped, and say so plainly where something is not viable.

06 — Evidence
What is shown, and what is not
What we can show today
- The box records each compartment opening without any patient input, which removes self-report bias by construction.
- The full chain is built and working end to end: blister, sensor box, patient app, dashboard.
- In our own development testing, compartment openings were detected without error over several months of continuous bench testing, and battery life reached 18 months at four openings per day. These are internal measurements; independent validation is planned.
What we have not shown yet
- Any effect on treatment results. Whether a reliable record of intake improves them is the question our pilots are designed to answer.
- A validated cost-offset figure for a specific insured population. We will not quote an ROI we cannot defend.
- Use over several months in patients' homes, which is what the first pilots will show.
07 — Pilot
What a study deployment looks like
- Cohort
- Study participants on oral medication, as defined in your protocol.
- Duration
- As specified in your protocol, plus a set-up and onboarding phase beforehand.
- What we measure
- Openings per dose and compartment, timing of each opening, missed and late doses, data completeness and participant retention.
- What we provide
- Boxes, blister supply via a licensed pharmacy partner, participant onboarding material, data export, and a named contact in Zurich.
- What we need from you
- A principal investigator, ethics approval, a data-management contact, and the dosing schedule per participant.
- What you get
- An analysis-ready intake dataset you own, and a description of the measurement method for your publication.
08 — Integration
Into the systems you already run
09 — Compliance
Where the data sits, and who may see it
10 — About us
Who you would be working with
DoryHealth is a Swiss company based in Zurich. We build and operate DoryGo ourselves, which means a pilot is run by the people who built the product rather than handed to an implementation team.
11 — Contact
Request a scoping call
Thirty minutes call. We ask about your cohort and your data environment, and find out together whether a pilot makes sense.
DoryHealth AG · Hagenholzstrasse 81a, 8050 Zürich
hello@doryhealth.com